Archive: 16/09/2016

Researchers say to conquer cancer you need to stop it before it becomes cancer

In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis ...

Sep 16, 2016

0

1500

Anticoagulation cuts TEC rate in adults after fontan surgery

(HealthDay)—For adults with atrial arrhythmia after Fontan operation, the risk of thrombotic and embolic complications (TEC) is reduced with anticoagulation therapy, according to research published in the Sept. 20 issue ...

Sep 16, 2016

0

1

Montreal meet seeks billions to boost AIDS, malaria, TB fights (Update)

International donors on Friday kicked off a drive to raise US$13 billion for fighting AIDS, tuberculosis and malaria, as Canadian Prime Minister Justin Trudeau vowed the killer diseases can be "eradicated" by 2030.

Sep 16, 2016

Early Rx with losartan doesn't slow kidney disease progression

(HealthDay)—For American-Indians with type 2 diabetes, early administration of losartan does not slow progression of glomerular filtration rate (GFR) decline, according to a study published online Sept. 9 in Diabetes Care.

Sep 16, 2016

0

4

Testosterone seems safe for hypogonadal prostate CA patients

(HealthDay)—For hypogonadal men with prostate cancer, testosterone treatment seems oncologically safe, according to a study published in the October issue of The Journal of Urology.

Sep 16, 2016

0

2

Recommending oral probiotics doesn't cut antibiotic use

(HealthDay)—Advising patients with asthma to take probiotics does not reduce antibiotic use, according to a study published in the September/October issue of the Annals of Family Medicine.

Sep 16, 2016

0

6

Nifedipine not superior to placebo for chronic chilblains

(HealthDay)—For patients with chronic chilblains, nifedipine is not superior to placebo, according to a study published in the September/October issue of the Annals of Family Medicine.

Sep 16, 2016

0

0

Tension-free vaginal tape-obturator has lasting benefit

(HealthDay)—The tension-free vaginal tape-obturator procedure is usually still effective at 10 years after the procedure, according to a study published in the October issue of The Journal of Urology.

Sep 16, 2016

0

0

What you need to know about hand, foot and mouth disease

A recent outbreak of hand, foot and mouth disease among college students in Florida has surprised many people, since it typically affects small children. However, a Baylor College of Medicine expert says anyone – even adults ...

Sep 16, 2016

Evolocumab safe, effective for those with dysglycemia, MetS

(HealthDay)—For patients with or without dysglycemia or metabolic syndrome (MetS), evolocumab is safe and efficacious for reducing low-density lipoprotein cholesterol at 52 weeks, according to research published online ...

Sep 16, 2016

0

0

page 2 from 7

«
»